A detailed history of United Capital Financial Advisers, LLC transactions in Baxter International Inc stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 18,019 shares of BAX stock, worth $587,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,019
Previous 14,955 20.49%
Holding current value
$587,959
Previous $500,000 36.8%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$32.85 - $40.26 $100,652 - $123,356
3,064 Added 20.49%
18,019 $684,000
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $133,090 - $176,333
-4,049 Reduced 21.31%
14,955 $500,000
Q1 2024

May 15, 2024

BUY
$37.88 - $43.77 $14,735 - $17,026
389 Added 2.09%
19,004 $812,000
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $342,499 - $420,698
10,801 Added 138.23%
18,615 $719,000
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $18,734 - $24,743
-502 Reduced 6.04%
7,814 $294,000
Q2 2023

Aug 14, 2023

SELL
$39.98 - $47.68 $144,727 - $172,601
-3,620 Reduced 30.33%
8,316 $378,000
Q1 2023

Aug 14, 2023

BUY
$37.58 - $52.57 $136,039 - $190,303
3,620 Added 43.53%
11,936 $484,000
Q1 2023

May 15, 2023

SELL
$37.58 - $52.57 $57,985 - $81,115
-1,543 Reduced 11.45%
11,936 $484,000
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $85,334 - $99,088
-1,717 Reduced 11.3%
13,479 $687,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $117,845 - $146,158
2,188 Added 16.82%
15,196 $818,000
Q2 2022

Aug 11, 2022

SELL
$63.83 - $80.0 $100,085 - $125,440
-1,568 Reduced 10.76%
13,008 $836,000
Q1 2022

May 16, 2022

SELL
$76.85 - $89.45 $9,990 - $11,628
-130 Reduced 0.88%
14,576 $1.13 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $26,472 - $30,952
355 Added 2.47%
14,706 $1.26 Million
Q3 2021

Nov 15, 2021

SELL
$73.77 - $83.61 $16,229 - $18,394
-220 Reduced 1.51%
14,351 $1.15 Million
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $11,672 - $12,761
145 Added 1.01%
14,571 $1.17 Million
Q1 2021

May 14, 2021

SELL
$76.38 - $86.03 $77,525 - $87,320
-1,015 Reduced 6.57%
14,426 $1.22 Million
Q4 2020

Feb 17, 2021

SELL
$75.39 - $82.36 $27,140 - $29,649
-360 Reduced 2.28%
15,441 $1.24 Million
Q3 2020

Nov 13, 2020

BUY
$78.33 - $90.73 $9,947 - $11,522
127 Added 0.81%
15,801 $1.27 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $14,788 - $17,698
188 Added 1.21%
15,674 $1.35 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $782,045 - $1.02 Million
-10,927 Reduced 41.37%
15,486 $1.26 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $988,432 - $1.14 Million
12,887 Added 95.28%
26,413 $2.21 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $1.53 Million - $1.69 Million
-18,788 Reduced 58.14%
13,526 $1.18 Million
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $208,643 - $234,126
-2,841 Reduced 8.08%
32,314 $2.65 Million
Q1 2019

May 14, 2019

BUY
$64.48 - $81.31 $189,506 - $238,970
2,939 Added 9.12%
35,155 $2.86 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $74,415 - $94,215
1,211 Added 3.91%
32,216 $2.12 Million
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $84,498 - $92,911
-1,195 Reduced 3.71%
31,005 $2.39 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $72,881 - $86,646
1,149 Added 3.7%
32,200 $2.38 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $216,019 - $249,513
-3,453 Reduced 10.01%
31,051 $2.02 Million
Q4 2017

Feb 13, 2018

BUY
$61.45 - $66.05 $210,343 - $226,089
3,423 Added 11.01%
34,504 $2.23 Million
Q3 2017

Nov 14, 2017

SELL
$59.5 - $64.61 $24,752 - $26,877
-416 Reduced 1.32%
31,081 $1.95 Million
Q2 2017

Aug 14, 2017

BUY
N/A
31,497
31,497 $1.91 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.